Annual Cash & Cash Equivalents
$40.91 M
+$4.82 M+13.35%
December 31, 2023
Summary
- As of February 7, 2025, NERV annual cash & cash equivalents is $40.91 million, with the most recent change of +$4.82 million (+13.35%) on December 31, 2023.
- During the last 3 years, NERV annual cash & cash equivalents has risen by +$15.56 million (+61.35%).
- NERV annual cash & cash equivalents is now -50.70% below its all-time high of $82.98 million, reached on December 31, 2016.
Performance
NERV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$26.53 M
-$4.35 M-14.09%
September 30, 2024
Summary
- As of February 7, 2025, NERV quarterly cash and cash equivalents is $26.53 million, with the most recent change of -$4.35 million (-14.09%) on September 30, 2024.
- Over the past year, NERV quarterly cash and cash equivalents has dropped by -$20.38 million (-43.44%).
- NERV quarterly cash and cash equivalents is now -71.12% below its all-time high of $91.85 million, reached on September 30, 2016.
Performance
NERV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NERV Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.3% | -43.4% |
| 3 y3 years | +61.4% | -43.4% |
| 5 y5 years | -18.6% | -43.4% |
NERV Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.7% | +13.3% | -56.3% | at low |
| 5 y | 5-year | -32.7% | +91.1% | -66.9% | +23.9% |
| alltime | all time | -50.7% | >+9999.0% | -71.1% | +5426.8% |
Minerva Neurosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $26.53 M(-14.1%) |
| Jun 2024 | - | $30.88 M(-11.3%) |
| Mar 2024 | - | $34.82 M(-14.9%) |
| Dec 2023 | $40.91 M(+13.4%) | $40.91 M(-12.8%) |
| Sep 2023 | - | $46.90 M(-9.4%) |
| Jun 2023 | - | $51.80 M(+44.0%) |
| Mar 2023 | - | $35.98 M(-0.3%) |
| Dec 2022 | $36.09 M(-40.6%) | $36.09 M(-10.3%) |
| Sep 2022 | - | $40.22 M(-19.2%) |
| Jun 2022 | - | $49.75 M(-9.5%) |
| Mar 2022 | - | $54.95 M(-9.6%) |
| Dec 2021 | $60.76 M(+139.6%) | $60.76 M(-7.4%) |
| Sep 2021 | - | $65.59 M(-11.6%) |
| Jun 2021 | - | $74.21 M(-7.4%) |
| Mar 2021 | - | $80.14 M(+216.0%) |
| Dec 2020 | $25.36 M(+18.4%) | $25.36 M(-22.0%) |
| Sep 2020 | - | $32.52 M(+0.8%) |
| Jun 2020 | - | $32.25 M(+7.4%) |
| Mar 2020 | - | $30.04 M(+40.3%) |
| Dec 2019 | $21.41 M | $21.41 M(-43.5%) |
| Sep 2019 | - | $37.91 M(+36.1%) |
| Jun 2019 | - | $27.84 M(-9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $30.61 M(-39.1%) |
| Dec 2018 | $50.23 M(+92.8%) | $50.23 M(-42.5%) |
| Sep 2018 | - | $87.30 M(+27.1%) |
| Jun 2018 | - | $68.69 M(+52.2%) |
| Mar 2018 | - | $45.13 M(+73.2%) |
| Dec 2017 | $26.05 M(-68.6%) | $26.05 M(-28.1%) |
| Sep 2017 | - | $36.25 M(-27.8%) |
| Jun 2017 | - | $50.19 M(-27.1%) |
| Mar 2017 | - | $68.89 M(-17.0%) |
| Dec 2016 | $82.98 M(+480.9%) | $82.98 M(-9.7%) |
| Sep 2016 | - | $91.85 M(+3.6%) |
| Jun 2016 | - | $88.67 M(+154.6%) |
| Mar 2016 | - | $34.82 M(+143.8%) |
| Dec 2015 | $14.28 M(-23.0%) | $14.28 M(-15.2%) |
| Sep 2015 | - | $16.84 M(-22.5%) |
| Jun 2015 | - | $21.74 M(-58.4%) |
| Mar 2015 | - | $52.20 M(+181.5%) |
| Dec 2014 | $18.55 M(+919.9%) | $18.55 M(-21.5%) |
| Sep 2014 | - | $23.64 M(+4824.9%) |
| Jun 2014 | - | $480.00 K(-77.6%) |
| Mar 2014 | - | $2.14 M(+17.8%) |
| Dec 2013 | $1.82 M(+807.8%) | $1.82 M |
| Dec 2012 | $200.30 K | - |
FAQ
- What is Minerva Neurosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Minerva Neurosciences?
- What is Minerva Neurosciences annual cash & cash equivalents year-on-year change?
- What is Minerva Neurosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Minerva Neurosciences?
- What is Minerva Neurosciences quarterly cash and cash equivalents year-on-year change?
What is Minerva Neurosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of NERV is $40.91 M
What is the all time high annual cash & cash equivalents for Minerva Neurosciences?
Minerva Neurosciences all-time high annual cash & cash equivalents is $82.98 M
What is Minerva Neurosciences annual cash & cash equivalents year-on-year change?
Over the past year, NERV annual cash & cash equivalents has changed by +$4.82 M (+13.35%)
What is Minerva Neurosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NERV is $26.53 M
What is the all time high quarterly cash and cash equivalents for Minerva Neurosciences?
Minerva Neurosciences all-time high quarterly cash and cash equivalents is $91.85 M
What is Minerva Neurosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, NERV quarterly cash and cash equivalents has changed by -$20.38 M (-43.44%)